CLINICAL_TRIALS
trial_result
· 2020-12-19
Clinical Trial Update: Antineoplaston Therapy in Treating Patients With Non-Hodgkin's Lymphoma [Phase 2]
Summary
Phase 2 trial update for antineoplaston therapy in non-Hodgkin lymphoma; study is terminated with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Burzynski Research Institute | Conditions: Non Hodgkin Lymphoma | Phase 2 | Status: TERMINATED | Results posted: 2020-12-19